Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01811446 · ClinicalTrials.gov registry record · NA

Evaluation of Muscle Activation Efficiency in Challenging Subjects

A NA study of Obesity and COPD, sponsored by Niveus Medical.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT01811446: Completed NA study of Obesity and COPD, sponsored by Niveus Medical.

NCT01811446 is a NA study of Obesity and COPD that has completed, run by Niveus Medical. The registered enrollment target is 30 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add start date to calendar (.ics) →

The verdict

NCT01811446, a NA study of Obesity and COPD, has completed, sponsored by Niveus Medical.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether muscle activation can be accomplished more effectively and comfortably in challenging subjects using novel configurations of an activation device. A novel device will be compared side by side with a market leading device.

Primary Outcome

Intensity required to achieve target levels of muscle contraction

Conditions Studied

Interventions

  • DEVICE Muscle Activation with Niveus and Intelect Devices

Study Locations (1)

California

  • Fogarty Clinical Research - Mountain View

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2013-03
Phase NA
Niveus Medical

2 total trials

What the finished NCT01811446 record still lists

NCT01811446 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (96% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Muscle Activation with Niveus and Intelect Devices is the first listed.

NCT01811446 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01811446 about?

NCT01811446 is a clinical study titled "Evaluation of Muscle Activation Efficiency in Challenging Subjects". The purpose of this study is to determine whether muscle activation can be accomplished more effectively and comfortably in challenging subjects using novel configurations of an activation device. A novel device will be compared side by side with a market leading device.

What is the current status of trial NCT01811446?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2013-03.

What conditions does trial NCT01811446 study?

This clinical trial studies the following conditions: Obesity, COPD.

What interventions are being tested in trial NCT01811446?

The interventions under investigation include: Muscle Activation with Niveus and Intelect Devices (DEVICE).

Who is sponsoring clinical trial NCT01811446?

This trial is sponsored by Niveus Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01811446 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01811446's enrollment target sits among peer trials

30 851st of 1053 higher than 173 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01811446, the US trial registry maintained by the National Library of Medicine. NCT01811446 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.